glp-1 and parkinson's A New Treatment Strategy for Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway Some epidemiologic studies have suggested

The STEP (Semaglutide Treatment Effect in People with obesity) programme comprised several large randomised controlled trials demonstrating consistent weight loss efficacy across diverse populations

In addition, although the L-carnitine group demonstrated numerically higher baseline LTI values, no statistically significant differences were observed between the study groups at baseline, suggesting the absence of a meaningful baseline imbalance

Stem Cells Dev

Sonu: Net ve Gvenli ereve GLP-1 kullanrken hamile kalnabilir Hamilelikte ve emzirme dneminde GLP-1 kullanlmaz Hamilelik renildiinde ila hemen braklr Sre mutlaka hekim kontrolnde ynetilmelidir GLP-1 gl bir aratr